Equities

Creightons PLC

Creightons PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)34.00
  • Today's Change6.00 / 21.43%
  • Shares traded1.30m
  • 1 Year change+33.33%
  • Beta0.8880
Data delayed at least 20 minutes, as of Nov 13 2024 15:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Creightons PLC's revenues fell -9.17% from 58.57m to 53.19m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 514.00k to a loss of 3.53m.
Gross margin42.92%
Net profit margin-6.63%
Operating margin-5.50%
Return on assets-8.64%
Return on equity-14.84%
Return on investment-11.83%
More ▼

Cash flow in GBPView more

In 2024, Creightons PLC increased its cash reserves by 89.84%, or 1.49m. The company earned 6.03m from its operations for a Cash Flow Margin of 11.33%. In addition the company used 608.00k on investing activities and also paid 3.95m in financing cash flows.
Cash flow per share-0.0248
Price/Cash flow per share--
Book value per share0.3223
Tangible book value per share0.2061
More ▼

Balance sheet in GBPView more

Creightons PLC has a Debt to Total Capital ratio of 15.09%, a lower figure than the previous year's 17.29%.
Current ratio2.34
Quick ratio1.46
Total debt/total equity0.1777
Total debt/total capital0.1509
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items dropped -889.28%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)-3.93%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-1,193.07
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.